The Hustle

So crispr-y

Investors in Crispr are bracing their wallets as experts believe their heavily hyped gene-editing procedure could lead to cancer. The Hustle Wed, Jun 13 Brought to you by Fundrise… billionaires aren’t the only ones who can be rich. Gene-editing treatment...

June 13, 2018

Daily briefings, straight to your inbox

Business and tech news in 5 minutes or less

Join over 1 million people who read The Hustle

Exit mobile version